More recently, strains of tuberculosis have emerged that are resistant not only to front - line antibiotics, but also to one or more drugs within each of the two most important classes of second - line drugs — broad - spectrum antibiotics
called fluoroquinolones, and injectable agents (amikacin, capreomycin and
kanamycin).